Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Maynard

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
The Journal of Pathology|December 18, 2020
Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomesHeidi Hempel Sullivan, Janielle P Maynard, Christopher M Heaphy, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 11, 2014
P2Y2 purinergic receptor activation is essential for efficient hepatocyte proliferation in response to partial hepatectomyBryan C Tackett, Hongdan Sun, Yu Mei, et al.
Analytical Chemistry|August 16, 2016
Objective Method for Presumptive Field-Testing of Illicit Drug Possession Using Centrifugal Microdevices and Smartphone AnalysisShannon T Krauss, Thomas P Remcho, Shelby M Lipes, et al.
The American Journal of Pathology|September 10, 2019
Lactoferrin CpG Island Hypermethylation and Decoupling of mRNA and Protein Expression in the Early Stages of Prostate CarcinogenesisCorey M Porter, Michael C Haffner, Ibrahim Kulac, et al.
Digital Biomarkers|February 26, 2020
A Pivotal Study to Validate the Performance of a Novel Wearable Sensor and System for Biometric Monitoring in Clinical and Remote EnvironmentsEllora Sen-Gupta, Donald E Wright, James W Caccese, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2021
Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancerEva Shrestha, Jonathan B Coulter, William Guzman, et al.
The Journal of Pathology|October 15, 2021
P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancerJanielle P Maynard, Jiayun Lu, Igor Vidal, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 12, 2023
P2Y2 purinergic receptor gene deletion protects mice from bacterial endotoxin and sepsis-associated liver injury and mortalityAthis R Arunachalam, Sanju S Samuel, Arunmani Mani, et al.
Plos One|June 30, 2021
GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United StatesIgor Vidal, Qizhi Zheng, Jessica L Hicks, et al.
The British Journal of Dermatology|April 1, 2018
Collagen deposition in chronic hidradenitis suppurativa: potential role for CD163<sup>+</sup> macrophagesA S Byrd, M L Kerns, D W Williams, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Pathology|December 18, 2020
Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomesHeidi Hempel Sullivan, Janielle P Maynard, Christopher M Heaphy, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 11, 2014
P2Y2 purinergic receptor activation is essential for efficient hepatocyte proliferation in response to partial hepatectomyBryan C Tackett, Hongdan Sun, Yu Mei, et al.
Analytical Chemistry|August 16, 2016
Objective Method for Presumptive Field-Testing of Illicit Drug Possession Using Centrifugal Microdevices and Smartphone AnalysisShannon T Krauss, Thomas P Remcho, Shelby M Lipes, et al.
The American Journal of Pathology|September 10, 2019
Lactoferrin CpG Island Hypermethylation and Decoupling of mRNA and Protein Expression in the Early Stages of Prostate CarcinogenesisCorey M Porter, Michael C Haffner, Ibrahim Kulac, et al.
Digital Biomarkers|February 26, 2020
A Pivotal Study to Validate the Performance of a Novel Wearable Sensor and System for Biometric Monitoring in Clinical and Remote EnvironmentsEllora Sen-Gupta, Donald E Wright, James W Caccese, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2021
Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancerEva Shrestha, Jonathan B Coulter, William Guzman, et al.
The Journal of Pathology|October 15, 2021
P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancerJanielle P Maynard, Jiayun Lu, Igor Vidal, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 12, 2023
P2Y2 purinergic receptor gene deletion protects mice from bacterial endotoxin and sepsis-associated liver injury and mortalityAthis R Arunachalam, Sanju S Samuel, Arunmani Mani, et al.
Plos One|June 30, 2021
GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United StatesIgor Vidal, Qizhi Zheng, Jessica L Hicks, et al.
The British Journal of Dermatology|April 1, 2018
Collagen deposition in chronic hidradenitis suppurativa: potential role for CD163<sup>+</sup> macrophagesA S Byrd, M L Kerns, D W Williams, et al.
Pageof 15